Cognex (NASDAQ:CGNX) Downgraded to "Hold" Rating by Wall Street Zen

Key Points

• Wall Street Zen downgraded Cognex from “Buy” to “Hold,” although analysts overall maintain a “Moderate Buy” consensus with an average price target of $75.64.
• Cognex shares opened at $64.22, up 4.1%, with a market capitalization of approximately $10.80 billion and a 12-month trading range of $34.60 to $72.88.
• The company beat quarterly EPS expectations, reporting $0.45 versus $0.42 expected, while revenue rose 16.9% year over year to $291.26 million; institutional investors own 88.12% of its stock.

Cognex (NASDAQ:CGNX - Get Free Report) was downgraded by stock analysts at Wall Street Zen from a "buy" rating to a "hold" rating in a research note issued on Sunday, Wall Street Zen reports.

A number of other research analysts have also weighed in on the company. Zacks Research raised Cognex from a "hold" rating to a "strong-buy" rating in a report on Tuesday, June 16th. DA Davidson set a $65.00 target price on shares of Cognex and gave the stock a "neutral" rating in a report on Monday, August 10th. Cantor Fitzgerald increased their target price on shares of Cognex from $76.00 to $84.00 and gave the stock an "overweight" rating in a research note on Friday, August 7th. Seaport Research Partners set a $75.00 price target on shares of Cognex in a report on Tuesday, May 26th. Finally, Truist Financial upped their price target on shares of Cognex from $71.00 to $78.00 and gave the stock a "hold" rating in a report on Friday, August 7th. Two analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $75.64.

Cognex Stock Up 4.1%

Cognex stock opened at $64.22 on Friday. The business's 50-day moving average price is $63.23 and its two-hundred day moving average price is $60.04. Cognex has a 12-month low of $34.60 and a 12-month high of $72.88. The stock has a market cap of $10.80 billion, a PE ratio of 62.35 and a beta of 1.49.

Cognex (NASDAQ:CGNX - Get Free Report) last posted its earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.42 by $0.03. Cognex had a return on equity of 13.50% and a net margin of 16.05%.The firm had revenue of $291.26 million for the quarter, compared to the consensus estimate of $292.10 million. During the same quarter in the prior year, the business posted $0.25 earnings per share. The business's quarterly revenue was up 16.9% on a year-over-year basis. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. As a group, analysts expect that Cognex will post 1.68 earnings per share for the current year.

Institutional Investors Weigh In On Cognex

Institutional investors and hedge funds have recently bought and sold shares of the business. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in shares of Cognex during the second quarter valued at approximately $26,000. Geneos Wealth Management Inc. boosted its holdings in Cognex by 402.2% in the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company's stock valued at $27,000 after acquiring an additional 736 shares in the last quarter. Rakuten Securities Inc. bought a new stake in Cognex in the second quarter valued at $32,000. Transamerica Financial Advisors LLC purchased a new position in Cognex during the 2nd quarter valued at $32,000. Finally, Elevation Wealth Partners LLC raised its holdings in Cognex by 635.4% in the 2nd quarter. Elevation Wealth Partners LLC now owns 478 shares of the scientific and technical instruments company's stock worth $35,000 after purchasing an additional 413 shares in the last quarter. Hedge funds and other institutional investors own 88.12% of the company's stock.

About Cognex

Cognex Corporation NASDAQ: CGNX develops machine vision technologies that help businesses automate inspection, identification, measurement and guidance tasks. Its systems enable manufacturing and logistics operations to analyze images and make decisions about products, components and packages.

The company's product portfolio includes industrial cameras, vision sensors, barcode readers, three-dimensional vision systems and machine vision software. Cognex also offers artificial intelligence and deep-learning tools designed to address complex inspection and classification applications, along with engineering, implementation and support services.

Founded in 1981 by Robert J.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.